Petition Requests Skin Treatment GRASE For Ophthalmic Monograph Ingredient
This article was originally published in The Tan Sheet
A beauty professional says an eye redness reliever containing tetrahydrozoline hydrochloride – included in FDA’s OTC monograph for ophthalmic drug products – safely and effectively controls redness from acne and other skin ailments. She requests adding the ingredient to the skin protectant drug monograph.
You may also be interested in...
Rx-to-OTC switch sponsors should not wait for FDA to act on NSURE before proposing innovative switch solutions, because reviewers are open to discussing ideas now, an agency official says. Some experts predict the new switch paradigm will not yield concrete regulatory changes, and are promoting other ways to expand OTC access.
John Chave, director-general at Cosmetics Europe, says the European Commission’s plan for targeted assessment of 28 potential endocrine-disruptors in cosmetics – despite its conclusion in late 2018 that the current cosmetics regulatory framework adequately addresses endocrine-disruptor concerns – is symptomatic of a broad trend taking hold in Europe.
Cosmetics Europe’s Director-General John Chave discusses next steps in the European Union’s proposed drive to ban manufactured microplastic in all cosmetic products. Industry continues to fight for something more proportionate, but it’s up against powerful forces in today’s European theater.